Evidence map›Paper›PMID 21738161›Full record

ReviewNature medicine2011

The immunology of stroke: from mechanisms to translation.

Costantino Iadecola, Josef Anrather

4 registry-linked trialsAbstract readReview
In one paragraph

Review in Nature medicine, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 4 registered trials, which are not on this map. Cited by 1,473 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1,473citing papers in PubMed, 3 pooled it
81.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02225834 phase4completednot on this map

Effects of Early Atorvastatin Treatment During the Acute Phase of Stroke on Immunoinflammatory Markers and Outcome in Patients With Acute Ischemic Stroke Classified as LAAS According TOAST Classification

TypeinterventionalSponsorUniversity of PalermoRan2011 to 2014Enrolled50ConditionsIschemic StrokeArmsAtorvastatin
NCT05512910 phase4active not recruitingnot on this mapstarted 2023, after this paper: background citation

Minocycline for Acute Ischemic Stroke Undergoing Endovascular Treatment Due to Basilar Artery Occlusion: a Randomized, Open-label, Proof of Concept Study

TypeinterventionalSponsorXijing HospitalRan2023 to 2025Enrolled90ConditionsIschemic Stroke, Acute, Minocycline, Endovascular Treatment, Basilar Artery OcclusionArmsMinocycline
NCT05982015 nacompletednot on this mapstarted 2024, after this paper: background citation

Multicenter, Randomized, Double-blind, Pseudo Treatment-controlled Clinical Study on the Efficacy and Safety of Remote Ischemic Conditioning in Preventing Stroke-associated Pneumonia

TypeinterventionalSponsorCapital Medical UniversityRan2024 to 2024Enrolled1,651ConditionsStrokeArmsRemote ischemic conditioning, Sham remote ischemic conditioning
NCT07754942 not yet recruitingnot on this mapstarted 2026, after this paper: background citation

Local-to-Systemic Inflammatory Biomarker Gradients and 90-Day Functional Outcomes in Patients With Acute Ischemic Stroke Due to Anterior Circulation Large Vessel Occlusion Undergoing Mechanical Thrombectomy: A Prospective Observational Cohort Study

TypeobservationalSponsorZhongshan Hospital Xiamen UniversityRan2026 to 2029Enrolled50ConditionsAcute Ischemic Stroke, Large Vessel OcclusionArmsProspective Mechanical Thrombectomy Cohort
3 · Its place in the literature

Who cites it

1,473 citing papers in PubMed, 3 syntheses or guidelines pooled it, 2,484 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Systemic immune-inflammation index predicts hemorrhagic transformation after endovascular therapy for ischemic stroke.Hypertension research : official journal of the Japanese Society of Hypertension · 2026
    Article
  12. Review
  13. A combined extract ofJournal of ginseng research · 2026
    Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article

1,413 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Costantino IadecolaDivision of Neurobiology, Department of Neurology and Neuroscience, Weill Cornell Medical College, New York, New York, USA. coi2001@med.cornell.edu
Josef Anrather
Cornell University · US

Funding

Role of COX-2 Gene Expression in Ischemic Brain DamageR01NS035806 · NINDS · WEILL MEDICAL COLL OF CORNELL UNIV · PI IADECOLA, COSTANTINO · 1997 to 2010
$3.5M
NO SYNTHASE GENE EXPRESSION AND CEREBRAL ISCHEMIC DAMAGER37NS034179 · NINDS · WEILL MEDICAL COLLEGE OF CORNELL UNIV · PI IADECOLA, COSTANTINO · 1999 to 2005
$1.8M
Prostanoid Receptors and Ischemic Brain InjuryR01NS056456 · NINDS · WEILL MEDICAL COLL OF CORNELL UNIV · PI IADECOLA, COSTANTINO · 2006 to 2010
$737k
NINDS NIH HHS NS35806NINDS NIH HHS R01 NS035806NINDS NIH HHS R01 NS056456NINDS NIH HHS R37 NS034179NINDS NIH HHS R37-NS34179
6 · The paper itself

Abstract

Immunity and inflammation are key elements of the pathobiology of stroke, a devastating illness second only to cardiac ischemia as a cause of death worldwide. The immune system participates in the brain damage produced by ischemia, and the damaged brain, in turn, exerts an immunosuppressive effect that promotes fatal infections that threaten the survival of people after stroke. Inflammatory signaling is involved in all stages of the ischemic cascade, from the early damaging events triggered by arterial occlusion to the late regenerative processes underlying post-ischemic tissue repair. Recent developments have revealed that stroke engages both innate and adaptive immunity. But adaptive immunity triggered by newly exposed brain antigens does not have an impact on the acute phase of the damage. Nevertheless, modulation of adaptive immunity exerts a remarkable protective effect on the ischemic brain and offers the prospect of new stroke therapies. As immunomodulation is not devoid of deleterious side effects, a better understanding of the reciprocal interaction between the immune system and the ischemic brain is essential to harness the full therapeutic potential of the immunology of stroke.

Indexed as

Adaptive ImmunityAnti-Inflammatory AgentsBrain InfarctionBrain IschemiaCell DeathHumansImmunity, InnateInflammationLymphocytesStrokeAnti-Inflammatory Agents

Identifiers

PMID21738161
PMCPMC3137275
OpenAlexW2118200665

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.